Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2000
10/11/2000EP1043344A1 Composition, particularly for cosmetics, containing star shaped polymers, the polymers themselves and their use
10/11/2000EP1043343A1 Composition, particularly for cosmetics, containing star shaped polymers, the polymers themselves and their use
10/11/2000EP1043031A1 Sustained release medicinal compositions
10/11/2000EP1043030A1 Sustained release medicinal compositions
10/11/2000EP1043026A2 Melanoma therapy
10/11/2000EP1043025A2 Renal cell carcinoma treatment
10/11/2000EP1043023A1 Viscous compositions containing carbon dioxide
10/11/2000EP1043020A1 Medicinal composition for percutaneous administration
10/11/2000EP1043016A1 A plant extract based on glycerides, a method for the preparation of this extract and a cosmetic composition containing the same
10/11/2000EP1042405A1 Gelatine compositions
10/11/2000EP1042388A1 Polyhydroxyalkanoate compositions having controlled degradation rates
10/11/2000EP1042348A1 Platelet derived growth factor (pdgf) nucleic acid ligand complexes
10/11/2000EP1042347A1 Dna pharmaceutical formulations comprising citrate or triethanolamine and combinations thereof
10/11/2000EP1042339A2 Carbohydrates, useful in solid delivery systems
10/11/2000EP1042291A1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
10/11/2000EP1042055A1 Use of cyclic carbonates
10/11/2000EP1042007A2 Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions
10/11/2000EP1042004A1 Method for tissue perfusion
10/11/2000EP1042003A1 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo
10/11/2000EP1042002A1 Pharmaceutical formulations and processes for their preparation
10/11/2000EP1041999A1 Thrombogenic polypeptide chimeras and conjugates having activity dependent upon association with tumor vascular endothelium
10/11/2000EP1041998A1 Composition and method for dermal and transdermal administration of a cytokine
10/11/2000EP1041996A1 Keratinocyte growth factor-2 formulations
10/11/2000EP1041995A1 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
10/11/2000EP1041993A1 Ophthalmic compositions and process of using
10/11/2000EP1041984A1 Pharmaceutical composition for oral administration
10/11/2000EP1041983A1 Application of enzyme prodrugs as anti-infective agents
10/11/2000EP1041978A1 Methods of inactivating bacteria including bacterial spores
10/11/2000EP1041975A1 Rate controlling membranes for controlled drug delivery devices
10/11/2000EP1041973A2 Microcapsules; process for preparing microcapsules containing a biologically active compound and liquid solution
10/11/2000EP1041972A1 Tablet for instant and prolonged release of one or more active substances
10/11/2000EP1041970A1 Compositions of microspheres for wound healing
10/11/2000EP1041969A2 Novel pharmaceutical compositions of uridine triphosphate
10/11/2000EP1041967A1 Microparticles and their therapeutic or diagnostic use
10/11/2000EP1041966A2 Pharmaceutical compositions
10/11/2000EP1041965A1 Tablet composition
10/11/2000EP1041962A1 Composition for cosmetic, dietetic or pharmaceutical use
10/11/2000EP1041895A1 Animal feed pelleting process and animal feed pellets produced therefrom
10/11/2000EP0914116B1 Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
10/11/2000EP0824916B1 Pranoprofen eyedrops containing organic amine
10/11/2000EP0778768A4 Formulations and methods for providing prolonged local anesthesia
10/11/2000EP0697860B1 Transdermal therapeutic system containing estradiol
10/11/2000EP0625068B1 Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of making and using them
10/11/2000CN1269717A Therapeutical system for transdermal delivery of leconorgestrel
10/11/2000CN1269716A Transdermal therapeutic system (TTS) for administrating sexual steroid hormones
10/11/2000CN1269377A Water soluble or water dispersant polymer salts
10/11/2000CN1269374A Carbamide and water soluble or water dispersant polymer salts
10/10/2000US6130321 High tap density chitosan, and methods of production
10/10/2000US6130209 Cascading polymers
10/10/2000US6130208 Formulation containing a nucleotide analogue
10/10/2000US6130204 Peptides
10/10/2000US6130200 Gel composition and methods
10/10/2000US6129916 Method of Increasing activation on proliferation of T cells using antibody-microbead conjugates
10/10/2000US6129915 Epidermal growth factor receptor antibodies
10/10/2000CA2126648C Liposomes containing bioavailable iron (ii) and method for obtaining them
10/10/2000CA2096417C Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy
10/10/2000CA1341114C Pharmaceutical formulations containing melphalan hydrochloride
10/08/2000CA2303992A1 Melanoma therapy
10/08/2000CA2303752A1 Renal cell carcinoma treatment
10/06/2000CA2304405A1 Cosmetic composition including polymers having a star structure, the said polymers and their use
10/06/2000CA2304404A1 Cosmetic composition including polymers having a star structure, the said polymers and their use
10/06/2000CA2304389A1 Cosmetic or pharmaceutical composition including polymers having a star structure, the said polymers and their use
10/05/2000WO2000058488A2 Delivery of functional protein sequences by translocating polypeptides
10/05/2000WO2000058271A1 Nitrogen mustard compounds and prodrugs therefor
10/05/2000WO2000057919A2 Lipid-based artificial particles inducing cell-mediated immunity
10/05/2000WO2000057918A2 Novel formulations comprising lipid-regulating agents
10/05/2000WO2000057916A1 Sphingomyelin containing preparation for the enhancement of tumor therapy
10/05/2000WO2000057906A1 Human papillomavirus vaccine with disassembled and reassembled virus-like particles
10/05/2000WO2000057897A1 Use of a lectin or conjugates for modulation of c-fibre activity
10/05/2000WO2000057890A1 Pulmonary delivery of protonated/acidified nucleic acids
10/05/2000WO2000057885A1 Pharmaceutical emulsions for retroviral protease inhibitors
10/05/2000WO2000057878A1 Thiadiazolyl urea or thiourea derivatives for antiviral treatment
10/05/2000WO2000057873A2 Granulate with high content of l-carnitine or an alkanoyl l-carnitine
10/05/2000WO2000057870A2 Viral treatment
10/05/2000WO2000057869A2 Viral treatment
10/05/2000WO2000057866A2 Use of azalide antibiotics for the topical treatment or prevention of ocular infections
10/05/2000WO2000057859A1 Novel formulations comprising lipid-regulating agents
10/05/2000WO2000057855A1 Solubilizing aids in powder form for solid pharmaceutical presentation forms
10/05/2000WO2000057854A2 Mechanically stable pharmaceutical presentation form containing liquid or semi-solid surface-active substances
10/05/2000WO2000057853A2 Pharmaceutical composition containing an extrusion additive
10/05/2000WO2000057852A2 Methods and compositions for treating solid tumors
10/05/2000WO2000057851A2 High potency dihydroergotamine compositions
10/05/2000WO2000057824A1 Transdermal therapeutic system with nicotine and addition of monoterpene ketones
10/05/2000WO2000057726A1 NUTRACEUTICALS HAVING N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER
10/05/2000WO2000057701A1 Prostaglandin compounds, compositions and methods of treating peripheral vascular disease and pulmonary hypertension
10/05/2000WO2000057699A1 Oral anti-odor compositions
10/05/2000WO2000032171A3 Autoahesive oral transmucosal delivery dosage form
10/05/2000WO2000029427A3 Antennapedia homeodomain helix 3 derived translocation vectors
10/05/2000WO2000020625A9 In vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction
10/05/2000WO1999053951A9 Terminally-branched polymeric linkers and polymeric conjugates containing the same
10/05/2000WO1999032135A8 Keratinocyte growth factor-2 formulations
10/05/2000DE19916383A1 Pharmazeutische Zusammensetzung mit einem Extrusionsstoff A pharmaceutical composition comprising an extrusion material
10/05/2000DE19914621A1 Stable aqueous solution of the thalidomide derivative EM 12 for parenteral administration in isotonic glucose solution has a specified pH, useful for treating immunological, hematologic and oncologic diseases
10/05/2000DE10004860A1 Pressurized air inhaler for administering drug-containing liposomal powder aerosol for treatment of respiratory disease, has nebulization chamber for drying aqueous liposome suspension
10/05/2000CA2707691A1 Sphingomyelin containing preparation
10/05/2000CA2368998A1 Delivery of functional protein sequences by translocating polypeptides
10/05/2000CA2368641A1 Use of a lectin or conjugates for modulation of c-fibre activity
10/05/2000CA2368587A1 High potency dihydroergotamine compositions
10/05/2000CA2367995A1 Novel formulations comprising lipid-regulating agents
10/05/2000CA2365128A1 Novel formulations comprising lipid-regulating agents
1 ... 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 ... 1712